This inventor holds 5 USPTO granted patents and 7 published patent applications and 1 EPO patent. Top assignees: Prometheus Biosciences, Inc., Cedars-Sinai Medical Center. Active years: 2020-2025.
Company Filing History:
5 out of 15 
4 out of 627 
Years Active: 2020-2025
Title: Innovations by Cindy T Dickerson
Introduction
Cindy T Dickerson is a prominent inventor based in Encinitas, California. She has made significant contributions to the field of medical science, particularly in the treatment of inflammatory diseases. With a total of five patents to her name, her work has the potential to impact many lives.
Latest Patents
Cindy's latest patents include innovative methods and systems for the selection and treatment of patients with inflammatory diseases. These patents describe methods for identifying subjects suitable for treatment with an inhibitor of CD30L activity or expression, such as an anti-CD30L antibody. The methods disclosed identify subjects based on the presence of a genotype indicative of a disease or condition for which an inhibitor of CD30L is a suitable treatment. Conditions such as Crohn's disease and primary sclerosing cholangitis are exemplary of the diseases targeted by her inventions. Additionally, she has developed humanized antibodies to TNF-like ligand 1A (TL1A) and pharmaceutical compositions for treating inflammatory bowel disease (IBD), including Crohn's Disease and ulcerative colitis.
Career Highlights
Cindy has worked with notable organizations such as Prometheus Biosciences, Inc. and Cedars-Sinai Medical Center. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Cindy has collaborated with esteemed colleagues, including Jeffry Dean Watkins and Stephan R Targan. These partnerships have further enhanced her research and development efforts in the medical field.
Conclusion
Cindy T Dickerson's innovative work in the treatment of inflammatory diseases showcases her dedication to improving patient outcomes. Her patents reflect her commitment to advancing medical science and her contributions will likely have a lasting impact on the field.